Cervical cancer, which can be prevented by a vaccine or detected early by Pap smears, kills 33,000 women in Latin America and the Caribbean a year, according to a new study.
At its debut 2 years ago, a vaccine that pre-vents cervical cancer was heralded as a public health breakthrough that could poten-tially save millions of women’s lives. Yet although the vaccine is now given routinely to young girls in the United States and Europe, it hasn’t been deployed in poorer countries, where it could make a bigger difference.
The National Partnership for Immunization will be hosting an informational conference call, offering media an opportunity to hear about current childhood vaccine safety issues and ask questions of vaccine experts.
Prof. Dr. Ciro A. de Quadros, co-chairman of the Pneumococcal Awareness Council of Experts (PACE), stated that there are seven children dying from diseases caused by pneumococcus bacteria every minute, pointing out that the pneumococcal conjugate vaccination was effective and safe in preventing such diseases.
ISTANBUL — Having convened in the 3rd Regional Pneumococcal Symposium held in Istanbul, experts lamented the low pneumococcal awareness level and called for the pneumococcal vaccine to be covered by social health insurance. Speaking at the press conference, Prof. Dr. Mehmet Ceyhan, Chairman of Turkish Association of Infectious Diseases, said that “Treatment of disease is not enough alone.